December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Activation Of Nitric Oxide Signaling Through M3 And M1 Muscarinic Receptor In Retina
Author Affiliations & Notes
  • A Berra
    Pathology School of Medicine Universidad Buenos Aires Buenos Aires Argentina
  • MJ Saravia
    Ophthalmology School of Medicine
    Universidad de Buenos Aires Buenos Aires Argentina
  • S Ganzinelli
    Pharmacology Unit School of Dentistry
    Universidad de Buenos Aires Buenos Aires Argentina
  • L Sterin-Borda
    Pharmacology Unit School of Dentistry
    Universidad de Buenos Aires Buenos Aires Argentina
  • E Borda
    Pharmacology Unit School of Dentistry
    Universidad de Buenos Aires Buenos Aires Argentina
  • Footnotes
    Commercial Relationships   A. Berra, None; M.J. Saravia, None; S. Ganzinelli, None; L. Sterin-Borda, None; E. Borda, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1442. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A Berra, MJ Saravia, S Ganzinelli, L Sterin-Borda, E Borda; Activation Of Nitric Oxide Signaling Through M3 And M1 Muscarinic Receptor In Retina . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1442.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Acetylcholine is recognized as a retinal transmitter substance implicated at some points in the visual system. The presence of nicotinic and muscarinic acethycholine receptors (mAChRs) in retina has been described. The aim of the present work was to identify in rat retina mAChR subtypes and determine whether pathways exists in rat retina for mAChRs and nitric oxide (NO), cyclic GMP (cGMP) accumulation. Method: The mRNA expression of both neural nitric oxide synthase (nNOS) and M1 and M3 mAChR subtypes were determinated by RT-PCR. Nitric oxide synthase (NOS) activity was determinated measuring L-[U-14C] citruline using L-[U-14C] arginine as substrate; cyclic GMP (cGMP) by RIA and pharmacological evidence for M1 and M3 mAChR subtypes was assessed using a mAChR agonist (carbachol) and antagonist (pirenzepine, 4-DAMP, AF-DX113). Results: The mRNA expression of both nNOS and M1 and M3 mAChR were demonstrated. Exposure of the rat retina to carbachol (10-11 M to 10-7 M) increased NOS activity and cGMP accumulation in a concentration-dependent manner. Pirenzepine (M1) and 4-DAMP (M3) but not AF-DX113 (M2), blocked these effects. The increase in NOS activity and cGMP content induced by carbachol was blumted by inhibitors of NOS activity (L-NMMA), calcium/calmodulin (TFP) and phospholipase C (U73122) while a protein kinase C (PKC) inhibitor (staurosporine) was without effect Conclusion: These data demostrate that NOS-cGMP pathway exists in retina and that they were linked to the activation of the M1 and M3 mAChR subtypes; contributing in the regulation and/or modulation of photoreceptor cells and various functions in the retina.

Keywords: 491 nitric oxide • 554 retina • 305 acetylcholine 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×